Condition (MeSH)
Mineralocorticoid Excess Syndrome, Apparent
ClinicalTrials.gov lists 5 trials for Mineralocorticoid Excess Syndrome, Apparent or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
5 of the 5 trials are tagged with Mineralocorticoid Excess Syndrome, Apparent itself; the rest are tagged with a narrower condition beneath it.
When did Mineralocorticoid Excess Syndrome, Apparent trials start? (5)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2/3
- Not applicable
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2018 | 1 |
| 2016 | 1 |
| 2012 | 1 |
| 2007 | 1 |
| 2002 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 5 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Mineralocorticoid Excess Syndrome, Apparent trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 2/3 | 1 |
| Not applicable | 1 |
| Observational | 2 |
How many Mineralocorticoid Excess Syndrome, Apparent trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Active, not recruiting | 1 |
| Completed | 4 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Mineralocorticoid Excess Syndrome, Apparent trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Celgene | 1 |
| The Royal Wolverhampton Hospitals NHS Trust | 1 |
Which publications cover Mineralocorticoid Excess Syndrome, Apparent? (2)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Apparent mineralocorticoid excess syndrome: an overview. | Arquivos brasileiros de endocrinologia e metabologia | 2004 | Yes |
| Impaired 11β-Hydroxysteroid Dehydrogenase Type 2 in Glucocorticoid-Resistant Patients. | The Journal of clinical endocrinology and metabolism | 2019 | No |
Prevalence (3)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Apparent mineralocorticoid excess | Point prevalence | <1 / 1 000 000 | Europe | Not stated | Unspecified |
| Apparent mineralocorticoid excess | Point prevalence | <1 / 1 000 000 | Europe | Not stated | Exact |
| Apparent mineralocorticoid excess | Point prevalence | <1 / 1 000 000 | Europe | Not stated | Exact |
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Apparent mineralocorticoid excess | 320 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Apparent mineralocorticoid excess | 320 | Exact | Orphadata Science knowledge files, Product 1 |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.